279
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature

, , , , , , , & show all
Pages 1978-1987 | Received 20 Jun 2011, Accepted 22 Aug 2011, Published online: 24 Oct 2011

References

  • Borovitz MJ, Chan JKC. Precursor lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, , editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. pp 167–178.
  • Lin P, Jones D, Dorfman DM, . Precursor B-cell lymphoblastic lymphoma. Am J Surg Pathol 2000;24:1480–1490.
  • Bergeron C, Pacquement H, Perel Y, . Treatment of childhood T cell lymphoblastic lymphoma (TLL), results of the SFOP LMT96. Blood 2005;106(Suppl. 1): Abstract 929.
  • Uyttebroeck A, Suciu S, Laureys G, . Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukemia, without radiotherapy: long term results of the EORTC CGL 58881 trial. Eur J Cancer 2008;44:840–846.
  • Trupiano JK, Bringelsen K, His ED. Primaty cutaneous lymphoblastic lymphoma presenting in an 8-week old infant. J Cutan Pathol 2002;29:107–112.
  • Shafer D, Wu H, Al-Saleem T, . Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients. Arch Dermatol 2008;144:1155–1162.
  • Sander CA, Medeiros LJ, Abruzzo LV, . Lymphoblastic lymphoma presenting in cutaneous sites. J Am Acad Dermatol 1991;25:1023–1031.
  • Cordell JL, Falini B, Erber WN, . Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219–229.
  • Sambouk J, Fritsch E, Maniatis T. Molecular cloning. In: A laboratory manual, Vol. III. New York: Cold Spring Harbor Laboratory Press; 1989. E.3.
  • Novara F, Beri S, Bernardo ME, . Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood. Hum Genet 2009;126:511–520.
  • Muljono A, Graf NS, Arbuckle S. Primary cutaneous lymphoblastic lymphoma in children: series of eight cases with review of the literature. Pathology 2009;41:223–228.
  • Maitra A, McKenna RW, Weinberg AG, . Precursor B-cell lymphoblastic lymphoma. Am J Clin Pathol 2001;115:868–875.
  • Kahwash SB, Qualman SJ. Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor B-cell lineage. Ped Develop Pathol 2002;5:45–53.
  • Link MP, Roper M, Dorfman RF, . Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983;61:838–841.
  • Biasotti S, Sementa AR, Zupo S, . A new pediatric case of cutaneous pre-B lymphoblastic lymphoma. Haematologica 2001;86:997–998.
  • Kawakami T, Kimura S, Kinoshita A, . Precursor B-cell lymphoblastic lymphoma with only cutaneous involvement. Acta Dermatol Venereol 2009;89:540–541.
  • Shon W, Vitkovski T, Cappel MA. Primary cutaneous precursor B-cell lymphoblastic lymphoma in an elderly patient. J Dermatol 2011;38:206–208.
  • Soslow RA, Baergen RN, Warnke RA. B-lineage lymphoblastic lymphoma is a clinic pathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer 1999;85:2648–2654.
  • Gupta R, Borkataky S, Aggarwal D, . Primary cutaneous B-cell lymphoblastic lymphoma. Indian J Dermatol Venereol Leprol 2008;74:652–654.
  • Kim JY, Kim YC, Lee ES. Precursor B-cell lymphoblastic lymphoma involving the skin. J Cutan Pathol 2006;33:649–653.
  • Schmitt IM, Manente L, Di Matteo A, . Lymphoblastic lymphoma of the pre-B phetotype with cutaneous presentation. Dermatology 1997;195:289–292.
  • Chimenti S, Fink-Puches R, Peris K, . Cutaneous involvement in lymphoblastic lymphoma. J Cutan Pathol 1999;26: 379–385.
  • Osone S, Hosoi H, Tanaka K, . A case of a Ewing sarcoma family tumor in the urinary bladder after treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2007;29: 841–844.
  • Borgmann A, Zinn C, Hartmann R, . Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer 2008;44:256–268.
  • Ducassou S, Ferlay C, Bergeron C, . Clinical presentation, evolution and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881 and EORTC 58951. Br J Haematol 2011;152:441–451.
  • Yeh KH, Cheng AL, Su IJ, . Prognostic significance of immunphenotypes in adult lymphoblastic lymphomas. Anticancer Res 1997;17:2269–2272.
  • Bernard A, Murphy SB, Melvin S, . Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 1982;59:549–554.
  • Donlon JA, Jaffe ES, Braylan RC. Terminal deoxynucleotidyl transferase in malignant lymphomas. N Engl J Med 1977;297: 461–464.
  • Bollum FJ. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 1979;54:1203–1215.
  • Janossy G, Hoffbrand AV, Greaves MF. Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukemia: a multiparameter analysis of 300 cases. Br J Haematol 1980;44:221–234.
  • Orazi A, Cattoretti G, John K, . Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol 1994;7:582–586.
  • Facchetti F, Jones DM, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Harris NL, , editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. pp 145–147.
  • Enver T. B-cell commitment: Pax-5 is the deciding factor. Curr Biol 1999;9:933–935.
  • Fuxa M, Busslinger M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax-5 in support of its B cell identity function. J Immunol 2007;178:3031–3037.
  • Schoumans J, Johansson B, Corcoran M, . Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukemia by tiling resolution array-based comparative genomic hybridization reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol 2006;135:492–499.
  • Usvasalo A, Savola S, Räty L, . CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study. Leuk Res 2008;32:1228–1235.
  • Xu W, Lu X, Kim Y, . Deletion of 14q24.1 approximately q24.3 in a patient with acute lymphoblastic leukemia: a hidden chromosomal anomaly detected by array-based comparative genomic hybridization. Cancer Genet Cytogenet 2008;185:43–46.
  • Yip SF, Wan TS, Chan LC, . Trisomy 4 as sole karyotypic abnormality in acute lymphoblastic leukemia: different clinical features and treatment response between B and T phenotypes? Cancer Genet Cytogenet 2006;164:94–95.
  • Mirebeau D, Acquaviva C, Suciu S, . The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 2006;91:881–885.
  • Strefford JC, van Delft FW, Robinson HM, . Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proc Natl Acad Sci USA 2006;103:8167–8172.
  • Schraders M, Van Reijmersdal SV, Kamping EJ, . High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genet Cytogenet 2009;191:27–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.